JP2002502375A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002502375A5 JP2002502375A5 JP1998550524A JP55052498A JP2002502375A5 JP 2002502375 A5 JP2002502375 A5 JP 2002502375A5 JP 1998550524 A JP1998550524 A JP 1998550524A JP 55052498 A JP55052498 A JP 55052498A JP 2002502375 A5 JP2002502375 A5 JP 2002502375A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/858,343 | 1997-05-19 | ||
| US08/858,343 US6130221A (en) | 1997-03-05 | 1997-05-19 | Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions |
| PCT/US1998/010218 WO1998052898A1 (en) | 1997-05-19 | 1998-05-19 | Pharmaceutical agents for the treatment of cerebral amyloidosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002502375A JP2002502375A (ja) | 2002-01-22 |
| JP2002502375A5 true JP2002502375A5 (enExample) | 2005-12-08 |
Family
ID=25328087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP55052498A Ceased JP2002502375A (ja) | 1997-05-19 | 1998-05-19 | 脳アミロイドーシスを治療するための薬物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6130221A (enExample) |
| EP (2) | EP1930308A1 (enExample) |
| JP (1) | JP2002502375A (enExample) |
| AU (1) | AU743845B2 (enExample) |
| CA (1) | CA2290818A1 (enExample) |
| DE (1) | DE69838785D1 (enExample) |
| WO (1) | WO1998052898A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5525339A (en) * | 1986-08-27 | 1996-06-11 | Dms Pharmaceutical Inc. | Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto |
| GB9911802D0 (en) * | 1999-05-20 | 1999-07-21 | Merck Sharp & Dohme | Therapeutic combination |
| KR20070049251A (ko) | 1999-10-27 | 2007-05-10 | 타녹스 인코퍼레이티드 | 조직 인자 길항제 및 그의 사용 방법 |
| EP1829535A3 (en) * | 1999-10-27 | 2007-10-24 | Tanox, Inc. | Tissue factor antagonists and methods of use thereof |
| AU2001253597A1 (en) * | 2000-04-12 | 2001-10-30 | Minerva Biotechnologies Corporation | Treatment of neurodegenerative disease |
| US20020160988A1 (en) * | 2001-02-20 | 2002-10-31 | Israel Institute For Biological Research | Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
| US7544681B2 (en) | 2001-09-27 | 2009-06-09 | Ramot At Tel Aviv University Ltd. | Conjugated psychotropic drugs and uses thereof |
| JP2005535565A (ja) * | 2002-03-04 | 2005-11-24 | ナイモックス コーポレーション | アルツハイマー病の症状を治療することが可能な化合物を決定する際に有用なスフェロン構成要素、並びに該構成要素から産生される治療および動物モデル |
| US7514407B2 (en) * | 2002-03-04 | 2009-04-07 | Nymox Corporation | Spheron component peptides and pharmaceutical compositions |
| MX2009000641A (es) | 2006-07-17 | 2009-02-12 | Univ Ramot | Conjugados que comprenden un farmaco sicotropico o un agonista de gaba y un acido organico y su uso en el tratamiento del dolor y otros desordenes del cns. |
| MX2012006566A (es) | 2009-12-09 | 2012-11-29 | Univ Ramot | Metodo para mejorar las funciones cognoscitivas. |
| CA2789654A1 (en) | 2010-02-24 | 2011-09-01 | Ramot At Tel-Aviv University Ltd. | Crystalline forms of the tri-mesylate salt of perphenazine-gaba and process of producing the same |
| WO2012038963A1 (en) * | 2010-09-22 | 2012-03-29 | Ramot At Tel-Aviv University Ltd. | An acid addition salt of a nortriptyline-gaba conjugate and a process of preparing same |
| CN103896729A (zh) * | 2012-12-28 | 2014-07-02 | 北大方正集团有限公司 | 一种制备4-氯双苯氯甲烷的方法 |
| CN114341100A (zh) | 2019-08-28 | 2022-04-12 | 联合利华知识产权控股有限公司 | 用于亮肤的新型化合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL93018C (enExample) * | 1957-10-22 | |||
| US3060242A (en) * | 1958-10-01 | 1962-10-23 | Dow Chemical Co | Aralkyl ether |
| US4540564A (en) * | 1982-05-18 | 1985-09-10 | University Of Florida | Brain-specific drug delivery |
| ES8308553A1 (es) * | 1982-06-17 | 1983-09-01 | Ferrer Int | "procedimiento de obtencion de nuevos derivados de piperazina". |
| BG41728A1 (en) * | 1984-12-28 | 1987-08-14 | Ninov | Crystal form of 1- benzhydryl- 4- adyl- piperazine dihydrochloride and method for its preparation |
| US5231170A (en) * | 1986-08-27 | 1993-07-27 | Paul Averback | Antibodies to dense microspheres |
| US4919915A (en) * | 1987-03-03 | 1990-04-24 | Paul Averback | Method for detecting the ability to prevent red-to-green congophilic birefringence |
| US4816416A (en) * | 1986-08-27 | 1989-03-28 | Paul Averback | Microspheric bodies for use in screening therapies for Azheimer's disease and related conditions |
| US5280032A (en) * | 1989-02-14 | 1994-01-18 | Toyama Chemical Co., Ltd. | 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
-
1997
- 1997-05-19 US US08/858,343 patent/US6130221A/en not_active Expired - Lifetime
-
1998
- 1998-05-19 CA CA002290818A patent/CA2290818A1/en not_active Abandoned
- 1998-05-19 EP EP07021294A patent/EP1930308A1/en not_active Withdrawn
- 1998-05-19 EP EP98923520A patent/EP0983222B1/en not_active Expired - Lifetime
- 1998-05-19 DE DE69838785T patent/DE69838785D1/de not_active Expired - Lifetime
- 1998-05-19 JP JP55052498A patent/JP2002502375A/ja not_active Ceased
- 1998-05-19 WO PCT/US1998/010218 patent/WO1998052898A1/en not_active Ceased
- 1998-05-19 AU AU75793/98A patent/AU743845B2/en not_active Ceased
-
2000
- 2000-10-06 US US09/680,327 patent/US6518314B1/en not_active Expired - Lifetime